Pharmaco - Press Releases

Date	Title	Company
26-May-2021	MEDICLINIC INTERNATIONAL PLC 2021 FULL-YEAR RESULTS ANNOUNCEMENT	Mediclinic
26-May-2021	SP delivers world’s largest installation of commercial freeze dryers for diagnostics production	SP Scientific Products
26-May-2021	Sermo and Bionical Solutions Partner to Expand Physician Access to Digital Treatment Support Tools Amidst Evolving Patient Education Needs	Sermo
26-May-2021	Autolus Therapeutics Announces an Additional Nature Publication for AUTO1	Autolus Therapeutics
26-May-2021	Advanced Biological Laboratories Receives CE-IVD Registration for its DeepChek® Whole Genome SARS-CoV-2 Genotyping Assay, the First CE-IVD Marked Kit for SARS-CoV-2 genotyping clinical applications	Advanced Biological Laboratories (ABL)
26-May-2021	TrakCel forms strategic partnership with BarTender to integrate advanced labeling solution within its second-generation cellular orchestration platform	TrakCel
26-May-2021	Clarity Pharma secures MHRA approval for second warehouse facility	Clarity Pharma
26-May-2021	ALM Translations enhances service offering with specialised workflow for Life Sciences clients	ALM Translations
26-May-2021	Nanoform and Celanese Explore Ways to Enhance Drug Delivery	Nanoform Finland Plc
26-May-2021	SYNLAB and Hospital District of Helsinki and Uusimaa extend partnership for comprehensive PCR-testing for SARS-CoV-2 in Finland	SYNLAB AG
25-May-2021	Genomics Market is expected to reach US$ 49,996.15 Mn by 2027 with Illumina, Inc.; Danaher; F. HOFFMANN-LA ROCHE LTD.; BIO-RAD LABORATORIES INC.; General Electric Company;	The Insight Partners
25-May-2021	Sermo and Bionical Solutions Partner to Expand Physician Access to Digital Treatment Support Tools Amidst Evolving Patient Education Needs	B3C newswire
25-May-2021	CROMSOURCE Announces Appointment of Kris O’Brien as Global Head of TalentSource Life Sciences	CROMSOURCE
25-May-2021	DEFENCE THERAPEUTICS ACCUVAC-D001 CANCER VACCINE GENERATES EFFECTIVE LONG-LASTING ANTI-TUMORAL RESPONSE	Defence Therapeutics Inc.
25-May-2021	Relief's Partner Acer Therapeutics Plans NDA Submission for ACER-001 in Q3 2021 Following Pre-NDA Meeting with FDA	RELIEF THERAPEUTICS Holdings AG
24-May-2021	Abivax reports excellent efficacy and safety of ABX464 in phase 2b clinical trial in ulcerative colitis and plans to proceed to phase 3	ABIVAX
24-May-2021	Long Read Sequencing Market is expected to reach US$ 5,334.68 million by 2028 With Oxford Nanopore Technologies; Tataa Biocenter; Illumina, Inc; Perkinelmer Inc.; F. Hoffmann-La Roche Ltd.; Baseclear B.V.; Bionano Genomics; Longas Technologies; Pacific Biosciences of California, Inc.; and Quantapore, Inc and others	The Insight Partners
24-May-2021	Abivax suspends trading of its shares until the publication of ABX464 Phase 2b results in ulcerative colitis	ABIVAX
24-May-2021	Diabetic Foot Ulcer Market to reach US$ 7,793.83 million by 2028 and to grow at a CAGR of 7.9%	theinsightpartners
24-May-2021	Rapid Nutrition Continues to Expand Flagship Wellness Brand with Support of Superstar Chef Jason Roberts	Rapid Nutrition PLC